TAKE Solutions Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, following a Board Meeting held on February 14, 2026. For the quarter ended December 31, 2025, the company reported total income of ₹0.30 Million, a significant decline compared to ₹1.70 Million in the previous quarter and ₹8.52 Million in the same quarter last year. The net profit for the quarter stood at ₹1.01 Million, which is a decrease from the profit of ₹6.29 Million in the previous quarter and a substantial drop from ₹47.68 Million in the corresponding quarter of the previous year. The performance reflects a period of strategic transition and restructuring within the organization.

TAKE Solutions Limited, established in 2000 and headquartered in Chennai, is a domain-intensive services provider primarily operating in the Life Sciences and Supply Chain Management sectors. In late 2025, the company announced a strategic pivot toward AI-driven healthcare, unveiling plans for an “advanced AI-powered Diagnostic & Preventive Care Platform” and the establishment of “One Minute Clinics” across India to enhance healthcare accessibility. Throughout 2025, the company underwent significant restructuring, including becoming debt-free following the divestment of its subsidiaries, Ecron Acunova Limited and TAKE Consultancy Services Inc.. Notable governance changes in late 2025 included the resignation of its CFO, Vedamirtham Venkatesan, and the appointment of new board members as part of its administrative realignment. While the company has seen its promoter shareholding decline sharply to near zero, it has attracted speculative interest, with its stock delivering multibagger returns of over 500% between March and December 2025. Individual retail investors now hold a dominant 99.44% stake in the company as of the December 2025 quarter.